Translational Development Acquisition (TDACW) Change in Cash (2024 - 2026)

Translational Development Acquisition (TDACW) has reported Change in Cash for 3 consecutive years, with $61247.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 135.74% year-over-year to $61247.0; the trailing twelve-month figure through Jun 2026 stood at $50622.0 (up 237.69% YoY), and the FY2025 full-year result was -$408387.0, down 193.63% from the prior year.
• Change in Cash climbed to $61247.0 in Q2 2026 per TDACW's latest filing, from -$5157.0 in the prior quarter.
• Across five years, Change in Cash topped out at $214136.0 in Q4 2024 and bottomed at -$231574.0 in Q1 2025.
• Historically, Change in Cash has averaged $1732.0 across 3 years, with a median of $3369.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Cash sank 108.11% in 2025, then soared 135.74% in 2026.
• Over 3 years, Change in Cash stood at $214136.0 in 2024, then tumbled by 108.11% to -$17363.0 in 2025, then soared by 452.74% to $61247.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $61247.0, -$5157.0, and -$17363.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.